Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion in Binge Drinking
NCT03169244Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Sep 2017
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcohol use disorder (AUD) comparing Bupropion with Placebo (2 arms). Primary endpoints: Change in Proportion of Binge Drinking Days at 12 weeks and Change in the Intensity of Binge Drinking at 12 weeks. Started Sep 2017; status: completed.
02
Drugs
bupropion
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT03169244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03169244.